Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Sep 02, 2026, 14:00 ET Greenberg Traurig Represents JATT III Acquisition Corp on Nasdaq IPO
Greenberg Traurig, P.A. represented JATT III Acquisition Corp (the Company) in the closing of its initial public offering of 6.9 million ordinary shares at a price of $10 per share Aug. 27,
More news about: Greenberg Traurig, LLP
Jun 29, 2026, 07:00 ET Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
participants in the solicitation of JATT II's shareholders in the proposed transaction and their ownership of JATT II's securities is, or will be, contained in JATT II's filings with the SEC. You can find more information about JATT II's directors and executive officers in JATT II's final prospectus related
More news about: Talawar Therapeutics